article thumbnail

MuseBeauty.Pro Now on LAB

Pivot Point International

This exciting partnership delivers cutting-edge makeup education designed to prepare students for success in the professional beauty industry, ensuring your school stands out to prospective students and keeps your current learners engaged. Look no further than MuseBeauty.Pro , now available through LAB !

Makeup 111
article thumbnail

2025 travel & wellness trends according to the experts

Spa Executive

Catherine Warren, Vice President of Strategic Partnerships, Arch Amenities Group, Boca Raton, Florida Looking to 2025, wellness travel will be shaped by hyperpersonalization, sustainability, and the growing demand for hybrid wellness experiences. The convergence of fitness and beauty is another key trend to watch.

article thumbnail

DEBRA Research, LEO Pharma Partner to Advance Treatments for EB

The Dermatology Digest

We are pleased to announce our non-exclusive partnership with LEO Pharma, which has demonstrated a strong track record in developing medicines for hard-to-treat skin conditions, saysProf.Hubert Truebel, MD, MBA, Managing Director at DEBRA Research, in a news release. There are currently no approved treatment options for EB.

article thumbnail

Rosy Smiles Big with After Pose Partnership

Salon Today

The software company announces partnership with the beauty industry photo marketing tool, which will help salons capture, edit, manage and share makeover images of their clientele.

article thumbnail

L+A Announces Media Partnership with The Skin Games 

Lipgloss and Aftershave

Lipgloss + Aftershave is proud to announce our media partnership with The Skin Games for the March 14-17, 2024 at the Westin Buckhead in Atlanta. Shawna Rocha is now the National Training Manager for Hale & Hush. We will be showcasing many elements of the 2024 event and then be on-site at the 2024 event covering the festivities.

article thumbnail

U.S FDA Approves Mirdametinib (Gomekli, SpringWorks) for Adult and Pediatric Patients With NF1-PN

The Dermatology Digest

It was very encouraging in the ReNeu trial to see that Gomekli provided deep and durable responses, with a manageable safety profile that enabled patients to stay on therapy. Gomekli demonstrated a manageable safety and tolerability profile. Every treatment approval is hard-won, built on research, persistence, and partnership.

article thumbnail

L’Oreal to Buy 10% Stake in Galderma

The Dermatology Digest

“We remain committed to Galderma and will continue managing our investment in the best interest of all its shareholders. The two companies are also teaming up for a new a scientific partnership focused on complementary research projects. “We I am very pleased to announce this strategic investment and partnership with Galderma.